Cargando...
Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer
Urothelial bladder cancer (UBC) is the most common malignant tumor of the urinary system. Most patients do not benefit from treatment with immune checkpoint inhibitors, which are closely associated with immune profiling in the context of UBC. Therefore, we aimed to characterize the immune profile of...
Guardado en:
| Publicado en: | Front Cell Dev Biol |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7990773/ https://ncbi.nlm.nih.gov/pubmed/33777927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.596484 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|